Form 4: Xylem SVP Cozad Receives Equity Awards

Xylem Inc.'s SVP & Chief Legal Officer, Stacy Cozad, was granted 735 restricted stock units and 2,579 non-qualified stock options, vesting over three years.

Summary

• SVP & Chief Legal Officer Stacy Cozad received equity awards from Xylem Inc.
• The awards include 735 restricted stock units (RSUs) and 2,579 non-qualified stock options.
• Both awards were granted on September 2, 2025, with a reference price/strike price of $140.35 per share.
• The restricted stock units and non-qualified stock options are scheduled to vest in one-third increments on March 5, 2026, March 5, 2027, and March 5, 2028.
• These awards were issued pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

Sentiment

Score: 7

Explanation: The filing reflects a standard executive compensation event, indicating stability and alignment of executive interests with long-term company performance. It's a neutral to slightly positive signal regarding executive retention and incentive structure.

Positives

• The grant of equity awards to a key executive like the SVP & Chief Legal Officer aligns management's long-term interests with those of shareholders.
• The multi-year vesting schedule for both RSUs and stock options incentivizes executive retention and sustained performance over time.

Future Outlook

The equity awards, structured with a multi-year vesting schedule and long-term option expiration, indicate an expectation of continued executive contribution and a focus on sustained long-term shareholder value creation by Xylem Inc.

Industry Context

This is a routine executive compensation disclosure, reflecting standard practices across industries where equity awards are used to incentivize and retain key talent. Such awards align executive interests with the company's long-term performance, a common strategy in the industrial technology and water solutions sector.

Comparison to Industry Standards

• The combination of restricted stock units (RSUs) and non-qualified stock options is a prevalent component of executive compensation packages across various sectors, including Xylem's industry.
• A vesting schedule of one-third increments over three years is a typical structure for long-term incentive plans, comparable to practices observed at peer companies such as Danaher Corporation or Pentair plc, which aim to foster executive retention and performance.
• The grant price of $140.35 for both RSUs and options is consistent with market-based pricing on the grant date, a standard benchmark for such equity awards.

Corporate Governance

Stakeholder Impact

• Shareholders: The equity awards align the executive's financial interests with the company's long-term stock performance, potentially benefiting shareholders.
• Employees: The executive compensation structure may influence broader employee incentive programs and retention strategies within the company.

Next Steps

• Continued vesting of restricted stock units and stock options on March 5, 2026, March 5, 2027, and March 5, 2028.
• Potential exercise of stock options by Stacy Cozad before the expiration date of September 2, 2035.

Key Dates

Recommendation

This Form 4 filing details a routine grant of equity awards to a senior executive. While it indicates continued executive alignment with company performance, it does not provide new financial or operational data that would warrant a change in investment recommendation. It's a standard compensation event, not a catalyst for significant stock movement.

Keywords

Xylem Inc., XYL, Form 4, Insider Transaction, Restricted Stock Units, Stock Options, Executive Compensation, Equity Awards, Stacy Cozad